Inside the research
Bruker Corporation
BRKR Research profile · latest available data
Price overview
$64.18
▲ +0.18 (+0.3%)
| 52w hi | $64.29 |
|---|---|
| 52w lo | $30.65 |
| Vol | 2.53M |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.08
| Short | +0.24 |
|---|---|
| Medium | +0.11 |
| Long | -0.33 |
computed 2026-09-27
Key fundamentals
Bruker Corporation
Healthcare · Medical Devices
| Market cap | $9.78B |
|---|---|
| Enterprise value | $11.50B |
| Forward P/E | 26.85x |
| EV / EBITDA | 21.26x |
| P / S (ttm) | 2.79x |
| Profit margin | -2.0% |
| Return on equity | -3.0% |
| Revenue growth | +5.2% |
| Debt / equity | 76.16 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.01 | |
| Sector | +0.08 | |
| Technical | +0.03 | |
| Earnings | +0.00 | |
| Sentiment | +0.19 |
macro × 1.00 · 2026-09-27
Business overview
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Risk Metrics
| Beta vs SPX | 1.21 |
|---|---|
| Corr SPX | 0.35 |
| Annual vol | 54.6% |
| Annual ret | +12.5% |
| Sharpe | 0.23 |
| Max DD | -58.5% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-14 | Other Material Event | read |
| 2026-08-04 | Earnings Release, Exhibits | read |
| 2026-07-30 | Other Material Event | read |
| 2026-05-21 | Shareholder Vote | read |
| 2026-05-15 | Other Material Event | read |
| 2026-05-06 | Earnings Release, Exhibits | read |
| 2026-04-28 | Other Material Event | read |
| 2026-04-10 | Officer / Director Change | read |
| 2026-04-01 | Officer / Director Change, Exhibits | read |
| 2026-02-20 | Officer / Director Change, Other Material Event | read |
| 2026-02-12 | Earnings Release, Exhibits | read |
| 2026-01-12 | Earnings Release, Reg FD Disclosure | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-11 | Munch Mark | Officer, EXEC VP&PRES BRU | Withheld for tax | 1.62K | $92.32K |
| 2026-08-11 | Herman Gerald N | Officer, EXECUTIVE VICE P | Withheld for tax | 1.41K | $80.40K |
| 2026-08-11 | LAUKIEN FRANK H | Director, Officer, 10%Own | Withheld for tax | 4.84K | $275.86K |
| 2026-08-10 | LAUKIEN FRANK H | Director, Officer, 10%Own | Withheld for tax | 4.56K | $257.04K |
| 2026-08-10 | Munch Mark | Officer, EXEC VP&PRES BRU | Withheld for tax | 1.57K | $88.59K |
| 2026-08-10 | Herman Gerald N | Officer, EXECUTIVE VICE P | Withheld for tax | 1.29K | $72.60K |
| 2026-08-09 | Herman Gerald N | Officer, EXECUTIVE VICE P | Withheld for tax | 1.60K | $85.46K |
| 2026-08-09 | LAUKIEN FRANK H | Director, Officer, 10%Own | Withheld for tax | 2.36K | $126.10K |
| 2026-08-09 | Munch Mark | Officer, EXEC VP&PRES BRU | Withheld for tax | 1.90K | $101.69K |
| 2026-07-15 | Munch Mark | Officer, EXEC VP&PRES BRU | Option exercise | 2.00K | $44.38K |
Flow & Concentration
| Insider 180d net | -$317.82K |
|---|---|
| Insider buys / sells | 0 / 3 |
| Insider bias | Neutral |
| 13F holders | 7 |
| Top-5 share | 99.8% |
| HHI | 5,611 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| Fidelity / FMR LLC | $1.22B | 20.24M |
| State Street Corp | $241.95M | 4.02M |
| AQR Capital Management | $149.49M | 2.51M |
| Capital Research / Capital World | $38.91M | 646.49K |
| Citadel Advisors | $19.70M | 327.30K |
| Bridgewater Associates | $2.55M | 42.34K |
| T. Rowe Price Group | $147.94K | 2.46M |
As of 2026-06-30
Dividends
| Yield (TTM) | 0.16% |
|---|---|
| $ / share (TTM) | $0.10 |
| 5y CAGR | +4.6% |
Annual dividend per share
| 2021 | $0.16 |
|---|---|
| 2022 | $0.20 |
| 2023 | $0.20 |
| 2024 | $0.20 |
| 2025 | $0.20 |
| 2026 | $0.05 |
SEC Filings
The Long Run
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $3.44B | +18.7% | |
| Gross profit | $1.51B | +19.4% | |
| Operating income | $68.20M | +7.2% | |
| Net income | $427.20M | +25.6% | |
| Cash from ops | $134.10M | -6.5% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $64.33 | $65.26 | $62.38 | $64.18 | 2.53M |
| Sep 24 | $59.17 | $65.00 | $59.17 | $64.00 | 2.26M |
| Sep 23 | $60.70 | $62.59 | $59.37 | $59.67 | 2.50M |
| Sep 22 | $62.29 | $62.47 | $60.91 | $61.21 | 1.98M |
| Sep 21 | $62.05 | $62.67 | $60.57 | $61.58 | 1.60M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →